Corteva CTVA Balance Sheet Statement
| Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | ||
|---|---|---|---|---|---|---|
| $2.51B+21.5% | $2.07B+2.8% | $2.01B-35.4% | $3.11B+28.3% | $2.42B+31.6% | ||
| $7.78B-10.3% | $8.67B+4.6% | $8.29B+46.1% | $5.68B-14.7% | $6.65B-12.7% | ||
| $5.31B+23.0% | $4.32B-15.9% | $5.13B-5.5% | $5.43B-4.3% | $5.67B+16.0% | ||
| $16.44B+2.7% | $16B-3.5% | $16.59B+9.9% | $15.1B-3.5% | $15.65B+1.9% | ||
| $4.2B+1.2% | $4.15B+1.2% | $4.11B+0.1% | $4.1B-2.6% | $4.21B+1.3% | ||
| $10.51B-0.1% | $10.52B+1.8% | $10.33B-0.7% | $10.41B-2.1% | $10.63B+1.3% | ||
| $42.2B+1.1% | $41.76B-0.9% | $42.12B+3.2% | $40.83B-2.6% | $41.91B+1.1% | ||
| $4.34B+13.3% | $3.83B-2.0% | $3.91B-3.3% | $4.04B+7.6% | $3.75B+13.7% | ||
| $483M+34.9% | $358M-86.4% | $2.63B-20.0% | $3.29B+666% | $429M+3.9% | ||
| $788M-38.6% | $1.28B+90.6% | $673M+34.6% | $500M0.0% | $500M— | ||
| $10.42B+9.5% | $9.52B-17.1% | $11.48B+10.5% | $10.39B-0.4% | $10.42B+16.4% | ||
| $6.32B+3.7% | $6.09B-0.4% | $6.12B-4.6% | $6.41B-1.5% | $6.51B-8.3% | ||
| $834M-45.6% | $1.53B+161% | $587M+967% | $55M-43.9% | $98M-90.1% | ||
| $25.22B-2.7% | $25.91B+6.7% | $24.29B+2.1% | $23.79B-3.8% | $24.74B-1.8% | ||
| $42.2B+1.1% | $41.76B-0.9% | $42.12B+3.2% | $40.83B-2.6% | $41.91B+1.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Corteva's total assets?
- Corteva (CTVA) holds $42.2B in total assets, up 0.7% year over year.
- How much debt does Corteva have?
- Corteva carries $788.0M in total debt against $25.2B of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Corteva have?
- Corteva holds $2.5B in cash and equivalents.
- Can Corteva cover its short-term obligations?
- Its current ratio is 1.58 — current assets exceed current liabilities.
- Where does Corteva's balance sheet data come from?
- Every line is extracted from Corteva's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
